Improvement in visual acuity at 3 months' · people with endophthalmitis following intraocular surgery
It is very uncertain whether vitrectomy changes proportion of people with a visual acuity improvement of 10 letters… compared with vitreous tap biopsy and antibiotic injection (very low certainty).
1 finding from 1 review
Visual acuity · children and adults with corneal abrasion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression of visual field loss (worsening of one or more stages, accordingto the Glaucoma Staging System‐2) (at 12 months) · participants with primary angle‐closure glaucoma
Phacoemulsification probably leads to lower progression of visual field loss (worsening of one or more stages,… compared with laser peripheral iridotomy (moderate certainty).
1 finding from 1 review
OR 0.35 [0.13, 0.91]
Studies not reported
Moderate
Mean change in maximum K from baseline or final value—at 12 months or more (diopters) · participants with keratoconus
1 finding from 1 review
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · participants with progressive keratoconus
1 finding from 1 review
Proportion of participants who gained 10 or more logMAR letters from baseline · participants with progressive keratoconus
It is very uncertain whether transepithelial CXL using iontophoresis changes proportion of participants who gained 10 or more logMAR letters from… compared with epithelium‐off CXL (very low certainty).
1 finding from 1 review
Proportion of participants who lost 10 or more logMAR letters from baseline · participants with progressive keratoconus
It is very uncertain whether transepithelial CXL using iontophoresis changes proportion of participants who lost 10 or more logMAR letters from… compared with epithelium‐off CXL (very low certainty).
1 finding from 1 review
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · participants with keratoconus
1 finding from 1 review
Proportion of participants who gained 10 or more logMAR letters from baseline · participants with keratoconus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants who lost 10 or more logMAR letters from baseline · participants with keratoconus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in maximum K from baseline or final value—at 12 months or more (diopters) · participants with progressive keratoconus
1 finding from 1 review
Progression to visual loss (loss of 3 or more lines on logMAR chart) · people with neovascular AMD
Radiotherapy showed no clear difference in loss of 3 or more lines of best‐corrected visual acuity Measured… compared with control (low certainty).
1 finding from 1 review
RR 0.82 [0.64, 1.04]
Studies not reported
Low
Progression to visual loss (loss of 3 or more lines on logMAR chart) · people with neovascular AMD
Radiotherapy combined with anti‐VEGF probably leads to higher loss of 3 or more lines of best‐corrected visual acuity Measured… compared with anti‐VEGF alone (moderate certainty).
1 finding from 1 review
RR 2.11 [1.4, 3.17]
Studies not reported
Moderate
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal fluocinolone acetonide implant 0.19 mg probably leads to higher gain of three or more lines visual acuity ‐ 12 months compared with sham (moderate certainty).
1 finding from 1 review
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg showed no clear difference in gain of three or more lines visual acuity ‐ 12 months compared with sham (moderate certainty).
1 finding from 1 review
Gain of 3 or more lines of visual acuity · macular edema in diabetes
It is very uncertain whether intravitreal triamcinolone acetonide injection 4 mg changes gain of three or more lines visual acuity ‐ 24 months** compared with sham (very low certainty).
1 finding from 1 review
RR 4.12 [0.48, 34.99]
Studies not reported
Very low
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal triamcinolone acetonide injection 4 mg showed no clear difference in gain of three or more lines visual acuity ‐ 12 months compared with macular laser (low certainty).
1 finding from 1 review
RR 0.85 [0.55, 1.3]
Studies not reported
Low
Gain of 3 or more lines of visual acuity · macular edema in diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg may leads to lower gain of three or more lines visual acuity ‐ 12 months compared with intravitreal antiVEGF (low certainty).
1 finding from 1 review
RR 0.99
Studies not reported
Low
Gain of 15 letters or more of visual acuity at 6 months · macular oedema secondary to branch retinal vein occlusion
Anti‐VEGF probably leads to higher gain of 15 letters or more of visual acuity at 6 months compared with sham (moderate certainty).
1 finding from 1 review